Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. (2021)

First Author: Hinks TSC
Attributed to:  The role of chronic bacterial airways infection in driving severe asthma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00263-0

PubMed Identifier: 34252378

Publication URI: http://europepmc.org/abstract/MED/34252378

Type: Journal Article/Review

Volume: 9

Parent Publication: The Lancet. Respiratory medicine

Issue: 10

ISSN: 2213-2600